Home Depot vs. Lowe's: Which Retail Giant Is Worth Betting On?

Home Depot's fiscal Q2 2026 revenue rose 5.7% year over year to $47.9B, with comparable sales up 1.7% and adjusted EPS up 5.1% to $4.92; Lowe's Q2 2025 sales were $24B, comps rose 1.1%, and adjusted EPS increased 5.6% to $4.33. Both stocks have declined over the past three months—5.9% for Home Depot and 8.1% for Lowe's—amid subdued home-improvement demand, while both trade below their five-year median forward P/E multiples. The article favors Home Depot for its market position and growth outlook, noting its Zacks #3 (Hold) rating versus Lowe's #4 (Sell); estimates for both companies have edged lower recently.

Analysis

The more useful signal is mix, not the headline sales comparison: contractor demand appears to be cushioning weak DIY activity. If that persists, Home Depot can defend share and ticket size, but Pro exposure also ties both chains more closely to construction and renovation cycles; it is not a hedge against a prolonged housing freeze. Home Depot’s acquisition-led growth adds a second question: whether distribution reach converts into organic share gains and earnings after integration costs. Lowe’s comparable-sales base and fiscal-period references are not directly comparable here, so avoid treating the reported growth-rate gap as a clean execution spread.

Near term, the tariff-refund contribution makes Home Depot’s gross-margin expansion less repeatable; underlying margin and expense productivity matter more than the reported figure. Over 1–3 months, estimate revisions and guidance are the likely catalysts, but both companies’ recent estimate drift argues against paying up for an uncomplicated recovery. Over 6–18 months, lower borrowing costs and improving housing turnover would support project demand; persistent high rates, weaker home prices, or delayed renovations would undermine the Pro thesis. Lowe’s lower multiple may offer more upside if execution closes the gap, but projected near-term EPS contraction makes it vulnerable to a value-trap narrative. The article provides no acquisition economics or standalone organic-growth data, so neither deal-driven upside nor dilution is yet quantifiable.

Key Decisions for Investors

• Prefer a measured long HD / short LOW relative-value position over an outright sector long, sized for housing-beta exposure. The thesis is relative execution and Pro share capture, not an immediate housing rebound; reassess if HD loses relative strength or its Pro-led comparable-sales advantage fades.
• Do not chase the reported HD margin improvement. Before adding, verify the next release’s gross margin excluding tariff-related benefits, comparable sales, and operating-expense leverage; persistent margin deterioration or weaker guidance would challenge the long leg.
• Keep LOW on a catalyst watch rather than buying solely on its valuation discount. A credible stabilization in EPS estimates and evidence that Pro expansion is translating into organic growth could narrow the valuation gap; further estimate cuts or continued relative underperformance would falsify that recovery case.
• Track U.S. mortgage rates, existing-home turnover, and renovation/project indicators over the next several months. A sustained improvement would support both names and could reduce the pair’s edge; rates remaining restrictive alongside soft demand would favor keeping exposure defensive.
• Request deal-level contribution, integration costs, and organic-growth disclosure before assigning value to acquisition-led expansion at either retailer. The article does not establish those economics, and the GMS reference alone is insufficient to form a GMS security view.